JP2006523708A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006523708A5 JP2006523708A5 JP2006510107A JP2006510107A JP2006523708A5 JP 2006523708 A5 JP2006523708 A5 JP 2006523708A5 JP 2006510107 A JP2006510107 A JP 2006510107A JP 2006510107 A JP2006510107 A JP 2006510107A JP 2006523708 A5 JP2006523708 A5 JP 2006523708A5
- Authority
- JP
- Japan
- Prior art keywords
- ngr1
- composition
- seq
- amino acids
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000000343 Nogo Receptor 1 Human genes 0.000 claims 28
- 108010041199 Nogo Receptor 1 Proteins 0.000 claims 28
- 108090000765 processed proteins & peptides Proteins 0.000 claims 20
- 150000001413 amino acids Chemical class 0.000 claims 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 12
- 229920001184 polypeptide Polymers 0.000 claims 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims 12
- 101100364401 Rattus norvegicus Rtn4r gene Proteins 0.000 claims 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 238000006467 substitution reaction Methods 0.000 claims 8
- 241000124008 Mammalia Species 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 208000035475 disorder Diseases 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 108060003951 Immunoglobulin Proteins 0.000 claims 4
- 230000004927 fusion Effects 0.000 claims 4
- 102000018358 immunoglobulin Human genes 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 230000008021 deposition Effects 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46342403P | 2003-04-16 | 2003-04-16 | |
| PCT/US2004/011728 WO2004093893A2 (en) | 2003-04-16 | 2004-04-16 | Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006523708A JP2006523708A (ja) | 2006-10-19 |
| JP2006523708A5 true JP2006523708A5 (https=) | 2007-05-31 |
Family
ID=33310776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006510107A Pending JP2006523708A (ja) | 2003-04-16 | 2004-04-16 | アミロイド斑に関連する状態の処置のためのＮｏｇｏレセプターアンタゴニスト |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070065429A1 (https=) |
| EP (1) | EP1615654A2 (https=) |
| JP (1) | JP2006523708A (https=) |
| KR (1) | KR20060023959A (https=) |
| CN (1) | CN1832752A (https=) |
| AU (1) | AU2004231742A1 (https=) |
| BR (1) | BRPI0409562A (https=) |
| CA (1) | CA2522649A1 (https=) |
| EA (1) | EA009643B1 (https=) |
| IS (1) | IS8081A (https=) |
| MX (1) | MXPA05011100A (https=) |
| NO (1) | NO20055392L (https=) |
| RS (1) | RS20050774A (https=) |
| WO (1) | WO2004093893A2 (https=) |
| ZA (1) | ZA200509242B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119165B2 (en) * | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| PT1534736E (pt) * | 2002-08-10 | 2010-09-07 | Univ Yale | Antagonistas do receptor nogo |
| US20080274112A1 (en) * | 2003-08-07 | 2008-11-06 | Lee Daniel H S | Nogo Receptor Antagonists |
| CA2549956C (en) * | 2003-12-22 | 2016-04-12 | Glaxo Group Limited | Immunoglobulins |
| CA2555018A1 (en) * | 2004-01-30 | 2005-08-18 | Biogen Idec Ma Inc. | Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists |
| US8269141B2 (en) | 2004-07-13 | 2012-09-18 | Lincoln Global, Inc. | Power source for electric arc welding |
| US9956639B2 (en) | 2005-02-07 | 2018-05-01 | Lincoln Global, Inc | Modular power source for electric ARC welding and output chopper |
| US9855620B2 (en) | 2005-02-07 | 2018-01-02 | Lincoln Global, Inc. | Welding system and method of welding |
| US9647555B2 (en) | 2005-04-08 | 2017-05-09 | Lincoln Global, Inc. | Chopper output stage for arc welder power source |
| CA2913655A1 (en) | 2006-01-27 | 2007-08-09 | Biogen Ma Inc. | Nogo receptor antagonists |
| EP2081429A4 (en) * | 2006-08-31 | 2010-01-06 | Biogen Idec Inc | PROCESS FOR PERIPHERAL ADMINISTRATION OF NOGO RECEPTOR POLYPEPTIDES |
| EP2276500A4 (en) | 2008-03-13 | 2015-03-04 | Univ Yale | REACTIVATION OF AXON GROWTH AND AXON RECOVERY IN CHRONIC REVERSE MARKET INJURIES |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) * | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) * | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) * | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) * | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4275149A (en) * | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) * | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US5179017A (en) * | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) * | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) * | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4366241A (en) * | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4510245A (en) * | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5168062A (en) * | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4968615A (en) * | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| GB9014932D0 (en) * | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
| WO1994004679A1 (en) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| JPH05244982A (ja) * | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | 擬人化ｂ−ｂ１０ |
| WO1999066041A1 (en) * | 1998-06-16 | 1999-12-23 | Human Genome Sciences, Inc. | 94 human secreted proteins |
| US6391311B1 (en) * | 1998-03-17 | 2002-05-21 | Genentech, Inc. | Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1 |
| US20020072493A1 (en) * | 1998-05-19 | 2002-06-13 | Yeda Research And Development Co. Ltd. | Activated T cells, nervous system-specific antigens and their uses |
| IL150566A0 (en) * | 2000-01-12 | 2003-02-12 | Univ Yale | Nucleic acids and polypeptides and nogo-receptor proteins |
| US7119165B2 (en) * | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| NZ525422A (en) * | 2000-10-06 | 2006-09-29 | Biogen Idec Inc | Isolated polynucleotides comprising a nucleic acid which encodes a polypeptide which modulates axonal growth in CNS neurons |
| JP2005507246A (ja) * | 2001-08-27 | 2005-03-17 | ノバルティス アクチエンゲゼルシャフト | Ｎｏｇｏレセプターホモログおよびそれらの使用 |
| WO2003035687A1 (en) * | 2001-10-22 | 2003-05-01 | Novartis Ag | Nogo receptor homologues and their use |
| PT1534736E (pt) * | 2002-08-10 | 2010-09-07 | Univ Yale | Antagonistas do receptor nogo |
| US20080274112A1 (en) * | 2003-08-07 | 2008-11-06 | Lee Daniel H S | Nogo Receptor Antagonists |
-
2004
- 2004-04-16 EP EP04759905A patent/EP1615654A2/en not_active Ceased
- 2004-04-16 CN CNA2004800169194A patent/CN1832752A/zh active Pending
- 2004-04-16 BR BRPI0409562-6A patent/BRPI0409562A/pt not_active IP Right Cessation
- 2004-04-16 EA EA200501620A patent/EA009643B1/ru not_active IP Right Cessation
- 2004-04-16 AU AU2004231742A patent/AU2004231742A1/en not_active Abandoned
- 2004-04-16 JP JP2006510107A patent/JP2006523708A/ja active Pending
- 2004-04-16 MX MXPA05011100A patent/MXPA05011100A/es not_active Application Discontinuation
- 2004-04-16 CA CA002522649A patent/CA2522649A1/en not_active Abandoned
- 2004-04-16 RS YUP-2005/0774A patent/RS20050774A/sr unknown
- 2004-04-16 KR KR1020057019510A patent/KR20060023959A/ko not_active Withdrawn
- 2004-04-16 WO PCT/US2004/011728 patent/WO2004093893A2/en not_active Ceased
- 2004-04-16 US US10/553,669 patent/US20070065429A1/en not_active Abandoned
-
2005
- 2005-10-21 IS IS8081A patent/IS8081A/is unknown
- 2005-11-15 ZA ZA200509242A patent/ZA200509242B/en unknown
- 2005-11-15 NO NO20055392A patent/NO20055392L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7112659B2 (en) | OB fusion protein compositions and methods | |
| ES2280083T3 (es) | Composiciones de proteinas de fusion ob y metodos. | |
| TWI816739B (zh) | 包含調酸素及免疫球蛋白片段之蛋白質接合物的液態製劑 | |
| JP6229038B2 (ja) | 修飾された血管作動性腸管ペプチド | |
| TW555765B (en) | Low molecular weight soluble tumor necrosis factor type-I and type-II proteins | |
| CN103118699B (zh) | 白介素-22在治疗病毒性肝炎中的应用 | |
| JP2006523708A5 (https=) | ||
| JP6290193B2 (ja) | ペグ化ｏｘｍ変異体 | |
| JP2017529059A5 (https=) | ||
| JP2011526303A5 (https=) | ||
| JP2003505347A5 (https=) | ||
| CA2480883A1 (en) | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins | |
| JP2008535800A5 (https=) | ||
| JP2016512213A5 (https=) | ||
| CN1446229A (zh) | 促生长素抑制素类似物 | |
| JP2020503262A5 (ja) | アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物 | |
| JP2024156886A (ja) | 増殖分化因子１５併用療法 | |
| CN104623639A (zh) | 白介素22二聚体在制备治疗胰腺炎药物中的应用 | |
| CN111741746A (zh) | 治疗自身免疫性疾病的方法 | |
| EP3169348B1 (en) | Pharmaceutical compositions comprising agonists of orexin-1 receptor ox1r for the treatment of inflammatory bowel diseases | |
| JP2018518485A5 (https=) | ||
| WO2019080919A1 (zh) | 充分剂量条件下治疗乙肝病毒相关肝病的药物和方法 | |
| WO2011013728A1 (ja) | 経粘膜吸収性を付与したモチリン類似ペプチド化合物 | |
| KR20090077935A (ko) | 내당능 장애 관련 증상을 예방하거나 치료하기 위한 인간 ｅｐｏ 수용체 작용제, 조성물, 방법 및 용도 | |
| JP2022542805A (ja) | メタロチオネイン抗体およびそれらの使用 |